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Abstract
Angiogenesis is very important for vascularized tissue engineering. In this study, we found that a two-dimensional co-
culture of human bone marrow stromal cell (HBMSC) and human umbical vein endothelial cell (HUVEC) is able to stimulate
the migration of co-cultured HUVEC and induce self-assembled network formation. During this process, expression of
vascular endothelial growth factor (VEGF165) was upregulated in co-cultured HBMSC. Meanwhile, VEGF165-receptor2 (KDR)
and urokinase-type plasminogen activator (uPA) were upregulated in co-cultured HUVEC. Functional studies show that
neutralization of VEGF165 blocked the migration and the rearrangement of the cells and downregulated the expression of
uPA and its receptor. Blocking of vascular endothelial-cadherin (VE-cad) did not affect the migration of co-cultured HUVEC
but suppressed the self-assembled network formation. In conclusion, co-cultures upregulated the expression of VEGF165 in
co-cultured HBMSC; VEGF165 then activated uPA in co-cultured HUVEC, which might be responsible for initiating the
migration and the self-assembled network formation with the participation of VE-cad. All of these results indicated that only
the direct contact of HBMSC and HUVEC and their respective dialogue are sufficient to stimulate secretion of soluble factors
and to activate molecules that are critical for self-assembled network formation which show a great application potential for
vascularization in tissue engineering.
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Introduction
In vascularized tissue engineering, formation of blood vessel
network is very important: oxygen and nutrient supply will be
insufficient due to the lack of blood vessel network [1]; cell loss
during the early post-implantational stage causes failure of bone
engineering and subsequent bone repair [2]. Vascular endothelial
growth factor (VEGF) and basic fibroblast growth factor (bFGF)
have been used for stimulating angiogenesis in many reports [3–6].
Recently, cell-based approaches have been applied in order to
improve tissue vascularization, among which endothelial cells
(ECs) have attracted most of the attention [7–12].
For studying the angiogenesis process in vitro based on endothelial
cells, numerous assay models have been applied. Among these
models, three-dimensional (3D) assays culturing endothelial cells on
a supportive matrix are most common [7–9,13–16]. Matrigel, as a
matrix derived from murine tumours, has been widely used for in
vitro tubule formation assay [7,16–17]. However, Donovan et al.
demonstrated that the tube formation stimulated by Matrigel are
not specific for endothelial cells: several non-endothelial cell types
could also be induced to form tube on Matrigel, indicating that the
tube formation by endothelial cells on Matrigel may not represent
true differentiation of this cell type [17].
Another tube formation in vitro assay involving co-culture of
endothelial cells with stromal cells with or without matrix has
attracted more and more attention [10–11,17–21]. Most of these
studies co-cultured endothelial cells with fibroblast to promote in
vitro vasculogenesis [17–21] However, Finkenzeller et al. and
Fuchs et al. established a co-culture system of human primary
osteoblastic cells and human primary endothelial cells to improve
neovascularization in bone tissue engineering applications [10–
11].
Each model has some advantages for studying specific steps
involved in the formation of tubular-like network. As our
laboratory focused on bone tissue engineering, regenerating bone
tissue with not only bone forming cells but also endothelial cells in
order to stimulate angiogenesis rapidly and obtain bone
reconstruction simultaneously seems attractive. Therefore, we
applied a co-culture model where human bone marrow stromal
cell (HBMSC) and human umbilical vein endothelial cell
(HUVEC) are cultured together in direct contact, trying to mimic
the in vivo physiological conditions under which angiogenesis is
triggered [19]. With this direct contact co-culture model, on the
one hand, we found that the co-culture of HBMSC with HUVEC
could stimulate the osteoblastic differentiation of HBMSC, which
suggested that the co-cultures could stimulate osteogenesis [22–
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HUVEC) migrated along co-cultured HBMSC (co-HBMSC) and
self-assembled into network structure, which suggested that co-
culture of osteoblastic cells with endothelial cells might be able to
stimulate angiogenesis in tissue engineering [22–23,25]. However,
the cellular and molecular events involved in this co-culture system
still remain unclear.
It may be hypothesized that there are complicate and
bidirectional cell-cell communications when two different types
of cells are co-cultured. For many years, our work is focused on the
better understating of this cell cooperation and the role of each cell
in the co-culture. There are three major ways for cells to talk each
other: the gap junction communications, the adherens and tight
junctions and the secretion of diffusible factors that can activate
specific receptors on the target cells [28]. Although we have
previously studied the roles of connexin-43 and neural-cadherin in
the osteoblastic differentiation of HBMSC co-cultured with
HUVEC [25,27], the mode of communication in co-culture
system of bone forming cells and endothelial cells that contributes
to self-assembled network structure is still unclear.
It has been demonstrated that migration of endothelial cells and
formation of tubular-like network structures called capillary cords
are critical steps for the angiogenesis and need the participation of
adherens molecules [9,29–31]. In endothelial cells, the predom-
inant adherens molecule is vascular endothelial-cadherin (VE-cad),
which is cell-specific and strictly located at the junctions of
endothelial cells [32]. The role of VE-cad in determining the
endothelial cell contact integrity, controlling the cellular junction
and tubular-like network formation has been extensively demon-
strated through functional studies in monocultures of endothelial
cells [5,33–35]. Bach et al. reported that inhibition of VE-cad not
only blocked the generation of capillary tubes but also disrupted
the preformed tubes [7]. Corada et al. found that the paracellular
permeability was increased and angiogenesis in vitro was blocked
when endothelial cells were cultured with VE-cad neutralizing
antibodies [33].
In addition, our previous studies demonstrated that expression
of VEGF165 was significantly upregulated in co-HBMSC [22].
VEGF has been reported in many studies on mono-cultured
endothelial cells that it could promote angiogenesis through
stimulating migration of mono-cultured endothelial cells, inducing
the phosphorylation and redistribution of adhesion junction
molecules, or increasing the expression of proteolytic enzyme
[36–40]. It is also well known that cells have to express proteolytic
enzymes allowing cleavage of matrix proteins for favouring cell
migration [41–42]. Although both of serine proteases of
plasminogen/plasmin system and matrix metalloproteinases are
important as proteolytic enzymes, the key enzyme of the
proteolytic machinery is uPA, which is produced via a receptor-
bound conversion of pro-uPA to active uPA [41,43]. Many studies
on mono-cultured endothelial cells have reported that VEGF165
plays an important role in this proteolytic process. Prager et al.
demonstrated that VEGF165 initiated proteolysis by activation of
pro-uPA via the VEGF-receptor 2 (KDR) and uPAR redistributed
to focal adhesions at the leading edge of endothelial cells in
response to VEGF165 [42].
However, although these molecules have been demonstrated
since many years that they are involved in tubular-like network
formation in mono-cultured endothelial cells in 2D cultures or in
3D systems, as far as we know, only role of VEGF on tube
formation in co-culture of endothelial cells and fibroblasts has
been reported [21,44]. The roles of uPA, uPAR and VE-cad in
tubular-like network formation in a co-culture system are still
unclear. Based on the importance of VEGF, uPA and uPAR in
mono-cultured endothelial angiogenesis [36–42] and our previous
findings in co-culture system about the functions of VEGF and
cadherin [22,25], we hypothesize that these molecules should play
an important role in the self-assembled network formation in a co-
culture of human stromal cells and endothelial cells.
Therefore, for the first time, we investigated the function links of
VE-cad, KDR, VEGF165, uPA and uPAR in the communication
between HBMSC and HUVEC which were co-cultured in 2D and
in direct contact, trying to explain the contribution of each type of
cells in the self-assembled network formation and the roles of key
vascular molecules in the self-assembled network formation. We
found that, in the co-culture system, co-HBMSC was responsible
for producing VEGF165 to activate its receptor-KDR in co-
cultured HUVEC. With the expression of VEGF165 and KDR, the
expression of proteolytic enzymes in co-HUVEC was stimulated
and the proteolytic machinery was initiated. Therefore, the co-
HUVEC could migrate and self-assembled into network structure.
VE-cad was found to be necessary for the self-assembled network
formation although it did not affect the migration of co-HUVEC.
Results
Expression of VE-cad during self-assembled network
formation in co-culture
In our previous studies, it has been demonstrated that self-
assembled network could be observed only in co-cultures of
HBMSC and HUVEC after 24 hours [22–23,25]. Here, the time
course process of the self-assembled network formation in the co-
cultures has been investigated and the results are shown in Fig. 1.
It can be seen that cells self-assembled during 6 to 24 hours and
formed network structure at 24 hours, as shown in Fig. 1 (left
column). On the contrary, no self-assembled network formation
could be observed in mono-cultured HBMSC and HUVEC.
To further understand the role of VE-cad on the self-assembled
network formation, the expression of VE-cad in HBMSC,
HUVEC, co-HBMSC and co-HUVEC at different time points
was detected after the co-cultured cells were separated (Fig. 2). We
can see that there is no significant difference between the
expression of VE-cad in HUVEC and co-HUVEC during the
development of self-assembled network (6 hours, 14 hours, and
18 hours), which were detected by Q-PCR and western blot
(Fig. 2A, B). The expression of VE-cad kept constant in HUVEC
and co-HUVEC during 6 hours-18 hours but significantly in-
creased in co-HUVEC when the self-assembled network formed at
24 hours. Therefore, co-HUVEC expressed much more VE-cad
than HUVEC at 24 hours. No VE-cad could be detected in
HBMSC or co-HBMSC, which indicated that the separation of
co-cultured cells was successfully. Interestingly, immunofluores-
cence staining of VE-cad (in red) on co-HUVEC showed that very
few VE-cad was detected at the junctions of cells after 6 hours and
14 hours of co-culture. At 18 hours, VE-cad appeared at junctions
of the co-HUVEC. When time increased, more and more VE-cad
(stained in red) appeared at the junctions of co-HUVECs (Fig. 2C
left column). The mono-cultured HUVEC kept confluence and
VE-cad appeared at cell junctions all the time (Fig. 2C right
column), whereas there is no VE-cad expression in HBMSC (data
not shown).
Expressions of VEGF165, KDR, uPA and uPAR were
regulated in co-culture
We further investigated the expression of VEGF165, KDR, uPA
and uPAR in HBMSC, HUVEC, co-HBMSC and co-HUVEC
during the self-assembled network formation. VEGF165 was not
expressed in HUVEC or co-HUVEC. However, we found that the
Vascular Actors in HBMSC-HUVEC Co-Culture
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VEGF165 was significantly upregulated in co-HBMSC as com-
pared with that in HBMSC. Interestingly, the expression of
VEGF165 in co-HBMSC reached peaks at 14 hours and 18 hours
followed by a sharp decrease at 24 hours (Fig. 3A). Meanwhile, the
gene expression of KDR was significantly upregulated in co-
HUVEC as shown in Fig. 3B and confirmed by immunofluores-
cence staining of KDR (in green) (Fig. 3E). Fig. 3C shows that uPA
was mainly synthesized in co-HUVEC and the upregulation of
uPA expression in co-HUVEC began at 14 hours and maintained
at 18 hours followed by a slight decrease at 24 hours. At 14 hours
and 18 hours, the expression of uPA in co-HUVEC was about
threefold higher than that in HUVEC. We also found that uPAR
was expressed by all cells and it was higher expressed in both co-
HBMSC and co-HUVEC than in mono-cultured cells (Fig. 3D).
Involvement of VE-cad, VEGF165, and uPAR in cell
migration and self-assembled network formation
To further understand the exact role of VE-cad, VEGF165 and
uPAR in the self-assembled network formation, functional studies
have been performed here using neutralizing antibodies which
have been demonstrated as efficient probes for studying these
molecules [5,33–35,45–48]. Migration of co-HUVEC and the self-
assembled network formation in the co-cultures with or without
these neutralizing antibodies were detected by time-lapse
videomicroscopy. It can be seen from Fig. 4A that neutralization
of VE-cad, VEGF165 and uPAR successfully suppressed the self-
assembled network formation (left column) without impairing the
cell viability (right column). Addition of isotype control mouse
antibodies or IgG control rabbit antibody had no effect on the
formation of self-assembled network. Interestingly, neutralization
of VE-cad did not stop the migration of co-HUVEC while the
neutralization of VEGF165 and uPAR totally blocked the
migration of co-HUVEC in co-culture system (Fig. 4B).
To further understand the role of VE-cad in the migration of co-
HUVEC and self-assembled network formation in the co-culture,
we detected the expression of VEGF165, uPA and uPAR in the
mono-cultured or co-cultured cells incubated with VE-cad
neutralizing antibody in order to see if VE-cad has strong effects
on these molecules’ expression. It can be seen from Fig. 5A that
neutralization of VE-cad has not significantly affected the
expression of VEGF165 in all cells but downregulated the expression
of uPA in co-HUVEC and uPAR in co-HBMSC transitionally
(Fig. 5B, C). However, the expression of uPA still maintained a
relative high level even after the downregulation (Fig. 5B). Different
from the mild effects of VE-cad on the expression of uPA and uPAR
in all cells, neutralization of VEGF165 significantly suppressed the
expression of uPA and uPAR in co-HBMSC and co-HUVEC and
the suppression started from 6 hours, affecting the cells all the time
except in co-HBMSC at 24 hours (Fig. 5D, E).
Figure 1. Light microscopy observation on HBMSC, HUVEC, co-HBMSC and co-HUVEC. Self-assembled network formed in co-cultures of
HBMSC and HUVEC after 6 hours, 14 hours, 18 hours, and 24 hours (Arrows). No self-assembled network formed in mono-cultured HBMSC and
HUVEC. Scare bars represent 200 mm.
doi:10.1371/journal.pone.0016767.g001
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PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e16767Figure 2. Expression of VE-cad in HBMSC, HUVEC, co-HBMSC and co-HUVEC after being cultured for different time. (A) The VE-cad
expression was detected by Q-PCR for mRNA level. Data of gene expression was quantified relative to VE-cad gene expressions of HUVEC after 6 h of
culture. During 6 hours–18 hours, the gene expression of VE-cad kept constant in HUVEC and co-HUVEC and there is no significant difference of VE-
cad gene expression in HUVEC as compared that in co-HUVEC. However, a significant increase of VE-cad gene expression in co-HUVEC was detected
at 24 hours while the gene expression of VE-cad in HUVEC still maintained constant. (B) The VE-cad expression was detected by western blot for
obtaining protein level. For western blot assay, a-tubulin was analyzed as loading control. The analysis was carried out based on three independent
experiments and the gel photos were taken as a representative (not show the other two experiment gel photos). There is no VE-cad detected in co-
HBMSC, which indicated the separation of co-cultured cells was completed. a indicated the difference p#0.05. VE-cad protein expression confirmed
the results of gene expression, which showed that there is no significant difference of VE-cad expression between HUVEC and co-HUVEC during
6 hours–18 hours but the co-HUVEC expressed much higher VE-cad than HUVEC at 24 hours. (C) Immunofluorensence staining of VE-cad in co-
HUVEC and HUVEC in red. Nuclear was stained in blue with DAPI. Scare bars represent 50 mm. VE-cad started to show at the junction of co-HUVEC
from 14 hours and located at the junction of HUVEC all the time.
doi:10.1371/journal.pone.0016767.g002
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Recently, co-cultures of endothelial cells with other cell types
have attracted more and more attention for studying angiogenesis
[10–11,18–19,21,44,49–54]. Most investigators chose fibroblast to
be co-cultured with endothelial to promote vascularisation with or
without stimulation by VEGF [18,21,49–54]. Focusing on bone
tissue engineering, our laboratory has been working on the co-
cultures of HBMSC and HUVEC for about ten years to
investigate the effects of HBMSC-HUVEC interactions on
osteoblastic differentiation of HBMSC and angiogenesis of
endothelial cells [22–27]. In this study, we further study the key
molecules actors involved in self-assembled network formation in
co-culture of HBMSC and HUVEC.
Although the molecules involved in angiogenesis and tube
formation are extensively studied in mono-cultured endothelial
cells or associated with a 3D matrix (Matrigel, for example),
nothing is known in a co-culture system where endothelial cells
form straight contacts with human stromal cells. There are at least
3 major mechanisms that are involved in endothelial cell
migration: (1) chemotaxis, the migration being directed by a
gradient of soluble chemoattractants; (2) haptotaxis, the migration
being directed by a gradient of immobilized ligands; (3)
mechanotaxis, the migration generated by mechanical forces
[31]. In addition to the above 3 major mechanisms that involve in
endothelial cell angiogenesis, the function of cadherin in migration
of cells and capillary tube formation has attracted more and more
attention in angiogenesis research [5,33–35]. However, all of these
studies are also based on mono-cultured endothelial cells or 3D
system [7,55–57].
Here, we studied the role of VE-cad in the self-assembled
network formation in 2D co-culture of HBMSC and HUVEC.
Although VE-cad expression has not changed during the
development of self-assembled network (6 hours to 24 hours)
(Fig. 2) and neutralization of VE-cad has slight effects on the
expression of VEGF, uPA and uPAR (Fig. 5A–C), the dynamic
localization of VE-cad was noticeable: it disappeared from the
junctions of co-HUVEC at 6 hours and 14 hours and appeared
again at the junctions of co-HUVEC at 18 hours and 24 hours
(Fig. 2).
Loss of VE-cad in cell-cell junctional regions has been reported
in many angiogenesis studies [6,32]. Wright et al. has reported that
complex of VE-cad and beta (b)-catenin were lost from adherens
junctions until recruited back to cell-cell contacts during the latter
stages of angiogenesis induced by type I collagen gel [6]. The
dissociation of complex of VE-cad and b-catenin from junctional
regions has been observed during junction remodelling in
endothelial cells subjected to fluid shear stress [32]. Interestingly,
the disappearance of VE-cad from junctional regions was not due
to a downregulation of expression or a degradation of VE-cad.
The reasons that induced the temporary loss of VE-cad from the
junctions have not been fully elucidated but the phosphorylation of
Figure 3. Expression of VEGF165, KDR, uPA and uPAR in HBMSC, HUVEC, co-HBMSC and co-HUVEC after being cultured for
different time. (A) Gene expression VEGF165 in HBMSC, HUVEC, co-HBMSC and co-HUVEC after being cultured for different time. Data of gene
expression was quantified relative to the same gene expression in HBMSC after 6 hours of culture (same in the following gene expression analysis). a
and b indicated the difference p#0.05 or p#0.01, respectively. Interestingly, we found that VEGF165 was only expressed by HBMSC and co-HBMSC
and VEGF165 expression in co-HBMSC is much higher than that in HBMSC during 6 hours–18 hours. However, this upregulation in co-HBMSC
diminished at 24 hours. (B) Gene expression of KDR in HBMSC, HUVEC, co-HBMSC and co-HUVEC after being cultured for different time. KDR was
mainly expressed by endothelial cells and it was much higher in co-HUVEC than in HUVEC from 14–24 hours. At 6 hours, no significant difference has
been observed. (C) Gene expression of uPA in HBMSC, HUVEC, co-HBMSC and co-HUVEC after being cultured for different time. uPA has a similar
expression style as to the expression of KDR. (D) Gene expression of uPAR in HBMSC, HUVEC, co-HBMSC and co-HUVEC after being cultured for
different time. uPAR expressed by all cells and it is higher expressed by co-cultured cells as compared to mono-cultured cell. (E) Immunofluorescence
staining of KDR in cells in green. Nuclear was stained in blue with DAPI. Scare bars represent 50 mm. It can be clearly seen that the expression of KDR
is much higher in co-cultured cells than in mono-cultured HUVEC. No much KDR could be detected in HBMSC by immunofluorescence.
doi:10.1371/journal.pone.0016767.g003
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association to the actin cytoskeleton, allowing VE-cad and b-
catenin to remain sequestered by the membrane and the rapid
return of this complex to adherens junctions when required [31].
In our opinion, this kind of loss-turnover redistribution of VE-cad
might facilitate the migration of HUVEC and the self-assembled
network formation: the disappearance of VE-cad could disorga-
nize the adherens junctions between HUVEC, which favoured the
cells to migrate; the turnover of VE-cad could tighten the adherens
junctions between HUVEC, which ensured the self-assembled
network to be formed.
Because the use of SiRNA introduces additional difficulties
(mainly the low transfection efficiency in human primary cells or
human stromal cells) while the efficiency of neutralizing antibodies
have been proved in previous studies [5,33–35,45–48], we have
selected several neutralizing antibodies against VE-cad, VEGF
and uPAR for functional studies. Neutralization of VE-cad has
light effects on the expression of uPA and uPAR and the effects
gradually diminished during the self-assembled network formation,
which might explain the migration of co-HUVEC even after the
treatment of VE-cad neutralizing antibody. However, the
migration was random, which was not like the migration of the
co-HUVEC observed in the co-cultures without VE-cad neutral-
izing antibody. In addition, we found that there was no self-
assembled network formation when the co-culture was treated
with VE-cad neutralizing antibody even there was still migration
of co-HUVEC. As lacking of VE-cad could disorganize the
adherens junctions between co-HUVEC, the migrating cells might
Figure 4. Functional studies of VE-cad, VEGF165 and uPAR. (A) HBMSC and HUVEC were co-cultured with neutralizing antibodies against VE-
cad, VEGF165 and uPAR for 24 hours. We found that the neutralization of VE-cad, VEGF165 and uPAR suppressed the formation of self-assembled
network in co-culture system without impairing the viability of cells. Addition of isotype control mouse antibody or normal IgG rabbit antibody had
no effect on self-assembled network formation. Scare bars represent 200 mm. (B) The migration velocity of co-HUVEC were analyzed from the images
taken by time-lapse videomicroscopy observing co-cultures with or without neutralizing antibody. Interestingly, co-HUVEC in co-culture incubated
with VE-cad neutralizing antibody was still be able to migrate. The migration speed is very close to the co-HUVEC in co-culture without any
neutralizing antibody. However, the neutralization of VEGF165 and uPAR totally blocked the migration of co-HUVEC in co-culture system.
doi:10.1371/journal.pone.0016767.g004
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network structure.
As we mentioned above, chemotaxis is one of the major
mechanisms involved in endothelial cell angiogenesis. Typically,
chemotaxis of endothelial cells is driven by growth factors such as
VEGF and bFGF [58]. VEGF is an angiogenic growth factor
possessing many special properties to induce endothelial cells to
proliferate, to migrate, to assemble into tubes, to survive and to
increase their permeability: VEGF is normally produced by cells
surrounding endothelial cells in close proximity; VEGF affects
endothelial cells via interactions with cellular receptors KDR and
VEGF receptor-1 [40,59].
In this study, the gene expression showed that VEGF165 was
mainly produced by HBMSC and it was upregulated in co-
HBMSC. However, in our previous and current studies, VEGF
protein was not detected in medium of co-culture while it was
quantified in HBMSC co-cultured with fibroblast cells [22]. We
assumed that the VEGF165 produced by co-HBMSC might be
consumed by co-HUVEC. Therefore, VEGF165 could act as a
chemotaxis and induced the co-HUVEC migration and self-
assembled network formation in a paracrine manner in our co-
culture system. In addition, Hurley et al. recently reported a
complex temporal regulation of capillary morphogenesis by
fibroblasts in a co-culture of fibroblast and endothelial cells [44].
They demonstrated that fibroblasts enhanced early capillary
network formation by assisting the endothelial cell migration and
increasing the VEGF and angiopoietin-1 expression but the effects
were temporary. Our study also found that the VEGF165
expression largely decreased in co-HBMSC after 24 hour culture
as compared to those at 14 and 18 hours, indicating that the
VEGF effects on cell migration and self-assembled network
formation might be transiently.
Roles of uPA and uPAR in migration and self-assembled
network formation have also been extensively studied in mono-
cultures and have been commonly considered as proteolytic
enzymes for degradation of matrix to initiate cell migration [41–
42,60]. In the present study, expression of uPA was significantly
enhanced in co-HUVEC and expression of uPAR was significantly
upregulated in all co-cultured cells, which might be a reason for
the migration of co-HUVEC and self-assembled network forma-
tion in the co-culture. In addition, the enhanced expression of uPA
in co-HUVEC might be in response to the upregulation of
VEGF165 in co-HBMSC, which further confirmed the chemotaxis
effects of VEGF165 on the migration of HUVEC and the self-
assembled network formation.
Functional studies showed that neutralization of VEGF165 and
uPAR totally blocked the endothelial cell migration and self-
assembled network formation in the co-culture. Neutralization of
VEGF165 resulted in the downregulation of uPA and uPAR gene
expression, indicating that the overexpression of proteolytic
enzyme in co-cultured cells was induced by VEGF165 and
suggesting that the migration of co-HUVEC and self-assembled
network formation in co-cultures of HBMSC and HUVEC
needed the participation of VEGF165 and uPA/uPAR.
In conclusion, in this study, we used a direct contact co-culture
model of HBMSC and HUVEC to study the key molecules
involved in the self-assembled network formation. Our findings
demonstrated that co-culture of HBMSC and HUVEC could
stimulate the migration of co-cultured HUVEC and induce the
self-assembled network formation through their contact and
specific dialogue. Here, the only direct contact of HBMSC and
HUVEC was sufficient to stimulate the secretion of key soluble
factors that are critical for self-assembled network structure:
VEGF165 was upregulated in co-HBMSC, which in turn activated
uPA through uPAR in co-HUVEC, probably triggering the
proteolytic machinery and initiating the migration of co-HUVEC
and self-assembled network formation. As adherens molecular,
VE-cad is necessary for the self-assembled network formation.
These new data in the field of cell to cell communication between
stromal cells and endothelial cells may have implications in study
of angiogenesis in bone tissue engineering.
Materials and Methods
Cell culture
Human bone marrow stromal cell (HBMSC) [25–26] and
human umbilical vein endothelial cell (HUVEC) [25–26] were
obtained and cultured according to methods described previously
[22,25–26,61–62]. Cells were either mono-cultured or co-cultured
for 24 h and samples were taken at different time points for
measurements. For immunofluorescence detection, cells were
cultured on glass coverslips in 24-well plates at the densities of
20,000 HBMSCs/cm
2 and 40,000 HUVECs/cm
2. Self-assembled
network formation was monitored by phase contrast microscopy
(Zeiss Axiovert 25, Seli, France).
Cell separation after co-culturing using magnetic beads
As VE-cad is particularly sensitive to trypsin in absence of Ca
2+,
mono-cultured HUVEC and co-cultured HUVEC were detached
in a way described before with minor modifications to maximally
preserve VE-cad at the cell surface and to avoid its degradation
[5]. HUVEC were separated from HBMSC by applying magnetic
beads coupled with an antibody against CD31, a specific protein of
ECs according to the methods established by Guillotin et al [23].
Quantitative real time polymerase chain reaction (Q-PCR)
Total RNA was prepared from cells using Total RNA Isolation
kit (NucleoSpin H RNA , MACHEREY-NAGEL) according to
the manufacture’s guidelines. Complementary DNA (cDNA) was
synthesized according to the protocols established by Grellier et al.
[22]. Primers of VE-cad, VEGF165, KDR, uPA and uPAR (all
from Eurogentec) were used as the final concentration of 250 nM;
their sequences are reported in Table 1. Data were analyzed with
the iCycler IQTM software and compared by the DDCt method
Figure 5. Gene expressions of VEGF165, uPA and uPAR in functional studies. (A) Gene expressions of VEGF165 in HBMSC, HUVEC, Co-HBMSC
and co-HUVEC cultured with (bars with shadow) or without VE-cad neutralizing antibody. Neutralization of VE-cad has no strong effects on
expression of VEGF165. (B) Gene expressions of uPA in HBMSC, HUVEC, Co-HBMSC and co-HUVEC cultured with (bars with shadow) or without VE-cad
neutralizing antibody. Neutralization of VE-cad significantly downregulated the expression of uPA in co-HUVEC at 14 hours and 16 hours and this
effect decreased at 24 hours. However, the expression of uPA in co-HUVEC still maintained a high level. (C) Gene expressions of uPAR in HBMSC,
HUVEC, Co-HBMSC and co-HUVEC cultured with (bars with shadow) or without VE-cad neutralizing antibody. uPAR was transiently affected by
neutralization of VE-cad. Its expression statistically decreased in co-HBMSC at 6 hours and 14 hours. (D) Gene expression of uPA in HBMSC, HUVEC,
Co-HBMSC and co-HUVEC with (bars with shadow) or without VEGF165 neutralizing antibody. Neutralization of VEGF165 strongly suppressed the
expression of uPA in co-HUVEC. (E) Gene expression of uPAR in HBMSC, HUVEC, Co-HBMSC and co-HUVEC with (bars with shadow) or without
VEGF165 neutralizing antibody. Gene expression of uPAR in co-cultured cells was downregulated all the time after the addition of VEGF165 neutralizing
antibody. a and b indicated the difference p#0.05 or p#0.01, respectively.
doi:10.1371/journal.pone.0016767.g005
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validation. Data was normalized to P0 mRNA expression for each
condition and was quantified relative to VEGF165, KDR, uPA and
uPAR gene expressions of HBMSC after 6 h of culture or relative
to VE-cad gene expression of HUVEC after being cultured for
6 h, which were standardized to 1.
Immunofluorescence
KDR (VEGF-R2) and VE-cad were detected by immunofluo-
rescence staining according to the procedures described in our
previous study [25] using a mouse anti-VEGFR2 primary
antibody and a mouse anti-VE-cadherin primary antibody,
respectively (BD Bioscience Pharmingen). Alexa 488 goat anti-
mouse IgG or Alexa 568 goat anti-mouse IgG secondary antibody
(Invitrogen) was used for revealing KDR and VE-cad in green and
red, respectively. Nuclei were revealed with 1 mg/ml 496-
diamidion-2-phenylindole (DAPI, FluoProbes) for 10 min at room
temperature. Cells were then observed with a fluorescence
microscope (Nikon Eclipse 80i, Japan) and images were taken by
a digital camera (Nikon Dxm 1200C, Japan).
Western blot
Protein extraction from cells was performed according to
previous description [23,25]. Quantification of the protein was
performed using BCA (bicinchoninic acid) protein assay kit
(Pierce, Perbio Science, Bezons, France).
Western blot analysis was carried out as previously described
[25]. Membranes were incubated with a primary rabbit anti-VE-
cad antibody (Cell Signalling Technology) diluted at 1/1000 in
blocking buffer (TBS-T: 20 mM Tris HCl, pH 7.4, 150 mM
NaCl, 0.05% (v/v) Tween 20) containing 5% (w/v) non fat milk).
Loading control was performed by incubating membrane with a
mouse monoclonal antibody against a-tubulin (Sigma) diluted at
1/30000 in blocking buffer. Immunoreactive bands were visual-
ized using horseradish-peroxidase-conjugated secondary antibod-
ies (HRP, goat anti-rabbit, Jackson ImmunoResearch Laborato-
ries, Inc.), or HRP goat anti-mouse for a-tubulin (Chemicon,
Euromedex, France) diluted at1/15000 in blocking buffer.
Membrane was immersed in enhanced chemiluminescence detect
reagent (ECL-plus, Amersham, BioSciences, France) and exposed
to KODAK photographic film. The intensities of the bands were
quantified by a Bio Imaging System (Gene Genius, Syngene) with
GeneTools software.
Time-lapse videomicroscopy
To find out the critical molecules for the migration of co-
HUVEC and the formation of self-assembled network, we
blocked VE-cad, VEGF165 and uPAR with neutralizing
antibody and monitored the migration of co-HUVEC and the
formation of self-assembled network in co-culture system by
time-lapse videomicroscopy. Time lapse videomicroscopy was
performed according to the method described by Grellier et al.
with slight modifications [22]. Briefly, HUVEC was labelled
with Dil-Ac-LDL (1,19-dioctadecyl-3,3,39,39-tetramethylindo-
carbocyanine perchlorate-Acetylated-Low Density Lipoprotein,
Harbor Bioproducts, USA) by incubating in culture medium
containing 0.2 mg/ml of Dil-Ac-LDL overnight. Then, HUVEC
stained with Dil-Ac-LDL and HBMSC were seeded in a special
culture chamber (Glass base dish,I W A K I ,J a p a n )a n di n c u b a t e d
at 37uCi na5 %C O 2 humid atmosphere with IMDM-10% (v/
v )F B Sf o r1 h o u rb e f o r et h ec h a m b e rw a ss e t t l e do na
thermostable plate sitting on the microscope (Leica, TCS
SP5), which allows for a stable temperature of 37uCi nt h e
chamber with 5% CO2 humid atmosphere. The microscope was
programmed to take an image every 10 minutes for 12 hours in
transmission and fluorescence. The obtained serial images could
be reconstructed into movies by the LAS-AF (Leica Advanced
Suite-Advanced Fluorescence) software. The migration speed of
co-HUVEC was obtained through calculating and averaging the
migration speed of every single cell by using Image J software
(NIH). Three independent experiments were performed for each
neutralizing antibody.
Functional studies
For neutralization experiments, HBMSC and HUVEC were
separately pre-treated with proper antibodies overnight before
they were cultured on glass coverslips or in 25 cm
2 flasks. As
controls, non-pre-treated cells were cultured without the neutral-
izing antibody. Mouse monoclonal antibody against human VE-
cad (Hycult Biotechnology) was used at 15 mg/ml, rabbit
polyclonal antibody against human VEGF165 (Millpore) was used
at 10 mg/ml and rabbit polyclonal antibody against human uPAR
(American Diagostica Inc.) was used at 5 mg/ml. Isotype mouse
antibody or normal IgG rabbit antibody have been used as control
antibodies. Live-dead assay was applied to the cells cultured with
or without neutralizing antibody to confirm their viability using
ethidium homodimer and calcein-AM regents.
Table 1. Primer sequences used in Q-PCR.
Transcript GenBank Primer sequences TM (6C)
VE-cad NM 001795 forward 59 GGC TCA GAC ATC CAC ATA ACC 39
reverse 39 CTT ACC AGG GCG TTC AGG GAC 39
63
VEGF165 AB021221 forward 59 TAT GCG GAT CAA ACC TCA CCA 39
reverse 59 CAC AGG GAT TTT TCT TGT CTT GCT 39
58
uPA NM 001145031.1 forward 59 CAC GCA AGG GGA GAT GAA 39 60
reverse 59 ACA GCA TTT TGG TGG TGA CTT 39
uPAR NM 001005376.1 forward 59 GCCCAATCCTGGAGCTTGA 39 60
reverse 59 TCCCCTTGCAGCTGTAACACT 39
P0 BC015690 forward 59 ATG CCC AGG GAA GAC AGG GC 39
reverse 59 CCA TCA GCA CCA CAG CCT TC 39
65
doi:10.1371/journal.pone.0016767.t001
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Data were expressed as means 6 standard deviation (SD) for
n=3 (three independent experiments) and were analyzed using
standard analysis of Student’s t-test. Differences were considered
significant when p#0.05 (a)o rp#0.01 (b).
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